Last 285.95 INR
Change Today +5.45 / 1.94%
Volume 42.2K
INDR On Other Exchanges
Symbol
Exchange
Natl India
As of 11:00 AM 10/23/14 All times are local (Market data is delayed by at least 15 minutes).

indoco remedies ltd (INDR) Snapshot

Open
282.00
Previous Close
280.50
Day High
288.00
Day Low
280.25
52 Week High
09/9/14 - 321.90
52 Week Low
10/28/13 - 75.50
Market Cap
26.4B
Average Volume 10 Days
161.7K
EPS TTM
6.29
Shares Outstanding
92.2M
EX-Date
07/21/14
P/E TM
45.5x
Dividend
1.40
Dividend Yield
0.49%
Current Stock Chart for INDOCO REMEDIES LTD (INDR)

Related News

No related news articles were found.

indoco remedies ltd (INDR) Related Businessweek News

No Related Businessweek News Found

indoco remedies ltd (INDR) Details

Indoco Remedies Limited manufactures and markets formulations and active pharmaceutical ingredients (APIs) in India and internationally. It provides anti-cold, anti-spasmodic, anti-infective, anti-inflammatory, stomatological, anti-fungal, cough and cold preparation, cardiovascular, multivitamin products, etc., as well as anti-bacterial, analgesic, anti-asthamic, anti-spasmodic products, etc. The company also provides anti-hypersensitive toothpaste, anti-septic gel, oral NSAID, antibacterial mouthwash and gel products, etc.; antibiotics and antiemetic products; ophthalmic and ENT products; and lipid lowering agents, antiulcerants, antispasmodics, nutrition and metabolism, diabetic neuropathic pain, steroid, anti-infective, and muscle relaxant products. In addition, it offers APIs in various therapeutic areas, such as antiurolithic, antidiabetic, antipsychotic, antiglaucoma, antihistaminic, antiinflammatory, antispasmodic, antilipemic, antiparkinsonian, and anticonvulsant. Further, the company provides contract research services comprising custom synthesis of molecules and intermediates; process chemistry research and development; non–infringing process designing and scale up; and analytical method development/validation, impurity profiling, and polymorphic studies, as well as contract manufacturing services. It serves general practitioners, consultant physicians, pediatricians, ENTs, cardiologists, diabetologists, endocrinologists, nephrologists, gynecologists, dentists, ophthalmologists, and orthopaedicians. The company, formerly known as Indo Continental Trading Company, was founded in 1945 and is based in Mumbai, India.

Founded in 1945

indoco remedies ltd (INDR) Top Compensated Officers

Managing Director, Chief Executive Officer, D...
Total Annual Compensation: 7.6M
Joint Managing Director, Executive Director, ...
Total Annual Compensation: 6.6M
Executive Chairman
Total Annual Compensation: 10.8M
Compensation as of Fiscal Year 2014.

indoco remedies ltd (INDR) Key Developments

Indoco Remedies Limited Reports Unaudited Standalone Earnings Results for the Second Quarter and Six Months Ended September 30, 2014

Indoco Remedies Limited. For the quarter, net sales/income from operation was INR 2,295.5 million against INR 1,986.3 million a year ago. Profit from operation before other income, finance cost and exceptional item was INR 354.8 million against INR 2.526 million a year ago. Profit form ordinary activities before tax was INR 333.6 million against INR 204.5 million a year ago. Net profit was INR 224.1 million against INR 160.4 million a year ago. Earnings per basic and diluted share before and after extraordinary items were INR 2.43 against INR 1.74 a year ago. For the six months, net sales/income from operation was INR 4,307.9 million against INR 3,495.5 million a year ago. Profit from operation before other income, finance cost and exceptional item was INR 625.8 million against INR 423.1 million a year ago. Profit form ordinary activities before tax was INR 583.5 million against INR 314.4 million a year ago. Net profit was INR 424.5 million against INR 252.2 million a year ago. Earnings per basic and diluted share before and after extraordinary items were INR 4.61 against INR 2.74 a year ago.

Indoco Remedies Limited, Q2 2015 Earnings Call, Oct 21, 2014

Indoco Remedies Limited, Q2 2015 Earnings Call, Oct 21, 2014

Indoco Remedies Limited to Report Q2, 2015 Results on Oct 21, 2014

Indoco Remedies Limited announced that they will report Q2, 2015 results on Oct 21, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
INDR:IN 285.95 INR 0.00

INDR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Ajanta Pharma Ltd 1,822 INR +8.30
Unichem Laboratories Ltd 204.80 INR +6.45
View Industry Companies
 

Industry Analysis

INDR

Industry Average

Valuation INDR Industry Range
Price/Earnings 35.6x
Price/Sales 3.3x
Price/Book 5.4x
Price/Cash Flow 23.6x
TEV/Sales 3.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INDOCO REMEDIES LTD, please visit www.indoco.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.